Why Moderna Stock Skyrocketed Today
The biotech could be on the verge of setting a new standard of care for skin cancer.
Overview
Shares of Moderna (NASDAQ: MRNA) soared on Wednesday after the vaccine maker announced potentially game-changing progress in the fight against cancer.
Image source: Getty Images.
Moderna and Merck (NYSE: MRK) are co-developing an experimental mRNA-based therapy, intismeran autogene, that's designed to activate an anti-tumor immune response based on the unique mutations of a patient's tumor.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.